Medtronic670-Blue

FAQ's

Answer : According to Precedence Research, the global generic drugs market size estimated at USD 390.57 billion in 2020 and is expected to hit around USD 574.63 billion by the end of 2027.

Answer : The low price of generic drugs as substitute to branded drugs is the supreme crucial factor in the growth of the global market for generic drugs.

Answer : The global generic drugs market is representing impressive CAGR of 5.59% during the forecast period 2021 to 2027.

Answer : In 2020, North America conquered the global market with a market share of more than 30%.

Answer : On the basis of drug type, simple generic drugs segment is expected hold largest revenue share in the forecast period of time 2021-2027. This growth is mostly attributed to low cost associated with the generic drugs over super generic drugs.

Answer : On the basis of therapeutic application, oncology therapeutic application segment accounted for the largest revenue with weighty share in 2020. This is attributed to increasing demand for the treatment of oncology disorders worldwide.

Answer : The key companies functioning in the worldwide generic drugs market are Mylan N.V. Abbott Laboratories, ALLERGAN, Teva Pharmaceutical Industries Ltd. Eli Lilly and Company, STADA Arzneimittel AG, GlaxoSmithKline Plc. Baxter International Inc. Pfizer Inc. Sandoz International GmbH among others.

Answer : Generic drugs refer to the drugs with a chemical make-up of a drug a like an existing branded drug. These medications are inexpensive and similar to branded drugs in power, and route of delivery, consistency, efficiency, and usage. These are subject to administration regulations in different nations, rather than associated with a particular company. These drugs are proven to be as safe and effective as their brand name formulation, which has already been marketed.